| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |